Tag: #Immunosuppression
-
Specific Meningoencephalitis in Kidney Transplant Patients A Rare and Serious Complication
Introduction: Immunosuppressive therapy, a necessity for kidney transplant recipients, can lead to serious complications, including infections. One such rare but critical infection is specific meningoencephalitis, commonly diagnosed in immunocompromised individuals. Visit https://www.clinnephrologyjournal.org/jcn for more groundbreaking research in nephrology and transplantation. Understanding Specific Meningoencephalitis Post-Kidney Transplantation Meningoencephalitis, particularly of tuberculous origin, is a severe neurological condition…
-
Post-Transplant Malignancy Risks, Prevention, and Management Strategies
Introduction: Post-transplant malignancy is one of the most concerning complications following Solid Organ Transplantation (SOT). The interplay between immunosuppressants, viral infections, and immune system modulation significantly contributes to cancer development in transplant recipients. As the demand for organ transplantation rises, understanding post-transplant malignancies, their risk factors, and prevention strategies becomes crucial. Visit Clinical Nephrology Journal…
-
A Rare Case of Hypothyroidism, Type 1 Diabetes Mellitus, and Systemic Lupus Erythematosus with Immunosuppressive Consequences
Introduction Autoimmune diseases often present in complex and overlapping patterns, making diagnosis and management a challenge. This case study highlights a rare coexistence of Systemic Lupus Erythematosus (SLE), Type 1 Diabetes Mellitus (T1DM), and Hypothyroidism, with immunosuppressive therapy leading to opportunistic infections. The interplay of these conditions presents significant clinical implications. Visit HSPIOA for more…
-
The Impact of Weight-Based Mycophenolate Mofetil Dosing
Introduction Mycophenolate Mofetil (MMF) plays a crucial role in post-kidney transplant immunosuppression. However, standard fixed dosing may not be ideal for all patients. A recent study evaluated a weight-based MMF dosing protocol to determine its safety and efficacy compared to a fixed-dose approach. Visit Clinical Nephrology Journal for more research updates in nephrology. Key Findings…
-
Tacrolimus Formulations in Renal Transplant Recipients Which One is More Effectiv
Introduction Tacrolimus is a crucial immunosuppressant used to prevent organ rejection in renal transplant recipients. However, maintaining therapeutic levels is challenging due to individual patient variations. A recent study compared three tacrolimus formulations—Immediate-Release (TAC-IR), Extended-Release Capsules (TAC-XL), and Extended-Release Tablets (TAC-XR)—to evaluate their effectiveness in keeping drug levels within the therapeutic range (TTR). Visit Horizon…
-
A Serious Pulmonary Infection Disseminated Strongyloidiasis in a Patient with Nephrotic Syndrome
Introduction Strongyloidiasis is a potentially fatal parasitic infection caused by Strongyloides stercoralis, affecting an estimated 300-400 million people worldwide. This case highlights the severe consequences of an undiagnosed Strongyloides stercoralis infection in an immunosuppressed patient with nephrotic syndrome. Visit https://www.hspioa.org/ for more groundbreaking research in this field. A Rare but Lethal Infection A 66-year-old male…
-
Equine Anti-Thymocyte Globulin ATGAM as an Alternative in Patients with Serum Sickness from Thymoglobulin
Introduction Thymoglobulin, a widely used rabbit-derived anti-thymocyte globulin (ATG), is a critical component in induction immunosuppression therapy for high-risk kidney transplant recipients. However, its use can sometimes trigger serum sickness, an immune-mediated reaction that causes fever, rash, and joint pain. A recent case study explores the successful administration of equine-derived ATGAM in a patient with…
Heighten Science Publications Inc. 